Aardvark Therapeutics(AARD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AARD Aardvark Therapeutics

Post-Mkt 10-20 19:53:45 EDT

3.90

+0.16

+4.28%

盘后3.90

+0.000.00%

19:30 EDT

High4.05	Low3.78	Vol66.70K
Open3.80	D1 Closing3.74	Amplitude7.26%
Mkt Cap84.62M	Tradable Cap43.56M	Total Shares21.70M
T/O259.32K	T/O Rate0.60%	Tradable Shares11.17M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AARD","market":"US","secType":"STK","nameCN":"Aardvark Therapeutics","latestPrice":3.9,"timestamp":1792526400000,"preClose":3.74,"halted":0,"volume":66695,"hourTrading":{"tag":"盘后","latestPrice":3.9,"preClose":3.9,"latestTime":"19:30 EDT","volume":1108,"amount":4321.2,"timestamp":1792539002676,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.04278074866310152,"floatShares":11168300,"shares":21696893,"eps":-3.207951,"marketStatus":"Post-Mkt","change":0.16,"latestTime":"10-20 19:53:45 EDT","open":3.8,"high":4.0514,"low":3.78,"amount":259316.8895255,"amplitude":0.072567,"askPrice":4.34,"askSize":100,"bidPrice":3.44,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.207951,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1792540800000},"marketStatusCode":4,"adr":0,"listingDate":1739509200000,"exchange":"NASDAQ","adjPreClose":3.74,"postHourTrading":{"tag":"盘后","latestPrice":3.9,"preClose":3.9,"latestTime":"19:30 EDT","volume":1108,"amount":4321.2,"timestamp":1792539002676,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.516122,"impliedVol":2.5211,"impliedVolPercentile":0.8085},"requestUrl":"/m/hq/s/AARD/wiki","defaultTab":"wiki","newsList":[{"id":"2676000795","title":"Aardvark Therapeutics Price Target Cut to $4.00/Share from $6.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2676000795","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676000795?lang=en_us&edition=fundamental","pubTime":"2026-10-19 19:06","pubTimestamp":1792407960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676502025","title":"Aardvark Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $4 from $6","url":"https://stock-news.laohu8.com/highlight/detail?id=2676502025","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676502025?lang=en_us&edition=fundamental","pubTime":"2026-10-19 18:18","pubTimestamp":1792405091,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261019:nAZN4TPUBZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674888866","title":"Aardvark Therapeutics Director Zhang Zhongwei Files Initial Beneficial Ownership Statement (Form 3)","url":"https://stock-news.laohu8.com/highlight/detail?id=2674888866","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674888866?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:48","pubTimestamp":1791492510,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics director Zhang Zhongwei files initial beneficial ownership statement (Form 3)Aardvark Therapeutics director Zhang Zhongwei filed an initial Form 3 on Oct. 8, 2026, covering his h","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL54kkm9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674700008","title":"Aardvark Therapeutics Adds Veteran Independent Board Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2674700008","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674700008?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:29","pubTimestamp":1791491345,"startTime":"0","endTime":"0","summary":"An announcement from Aardvark Therapeutics, Inc. ( ($AARD) ) is now available. On October 7, 2026, Aardvark Therapeutics appointed David (Zhongwei)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aardvark-therapeutics-adds-veteran-independent-board-director?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aardvark-therapeutics-adds-veteran-independent-board-director?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673207445","title":"Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.d., MBA, to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673207445","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673207445?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460810,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nTUA4D1ML9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673741710","title":"Press Release: Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673741710","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673741710?lang=en_us&edition=fundamental","pubTime":"2026-10-08 20:00","pubTimestamp":1791460800,"startTime":"0","endTime":"0","summary":"Brings more than 25 years of experience in clinical strategy, biostatistics and regulatory submissions from Abivax, Alumis, MyoKardia and Genentech/RocheSAN DIEGO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Aa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","BK4022","R","BK4232","BK4007","PWS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672779746","title":"Aardvark Therapeutics Grants New Hire Stock Option for 60,000 Shares at $5.27","url":"https://stock-news.laohu8.com/highlight/detail?id=2672779746","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672779746?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:05","pubTimestamp":1790971514,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics grants new hire stock option for 60,000 shares at $5.27Aardvark Therapeutics granted a new employee a stock option for 60,000 common shares on Oct. 1, 2026.Exercise price set at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nNDL5X8vM3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","LU2210150020.SGD","AARD","IE00B64PRP62.GBP","BK4585","IE00BQXX3C00.GBP","IE00BN0W2V16.EUR","NDAQ","IE00BKPKM429.USD","BK4007","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","IE00BQXX3F31.USD","SG9999014005.SGD","IE00BN0W2T93.GBP","BCDF","BK4112","BK4588","SG9999014039.USD","SG9999014021.USD","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669914744","title":"Aardvark Therapeutics' ARD-101 Path Forward May Be Challenging, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2669914744","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669914744?lang=en_us&edition=fundamental","pubTime":"2026-09-24 23:20","pubTimestamp":1790263205,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics (AARD) faces a \"potentially challenging\" path forward for ARD-101 in Prader-Willi syndrome, with unblinded data from a halted phase 3 study expected to provide additional insight","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669495651","title":"Aardvark Therapeutics Price Target Maintained with a $6.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2669495651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669495651?lang=en_us&edition=fundamental","pubTime":"2026-09-24 21:37","pubTimestamp":1790257020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AARD/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667690584","title":"RBC Capital Keeps Their Hold Rating on Aardvark Therapeutics, Inc. (AARD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667690584","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667690584?lang=en_us&edition=fundamental","pubTime":"2026-09-15 09:46","pubTimestamp":1789436774,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Hold rating on Aardvark Therapeutics, Inc. yesterday and set a price target of $6.00. According to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-hold-rating-on-aardvark-therapeutics-inc-aard-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-hold-rating-on-aardvark-therapeutics-inc-aard-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657707","title":"Aardvark Therapeutics CFO and COO Sun Nelson Disposes of USD 395,790.45 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657707","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657707?lang=en_us&edition=fundamental","pubTime":"2026-09-12 08:14","pubTimestamp":1789172070,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics CFO and COO Sun Nelson disposes of USD 395,790.45 in common sharesAardvark Therapeutics CFO and COO Sun Nelson sold 76,754 common shares on Sept. 10-11.Sales priced at USD 5 and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260912:nNDL1WKHyk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Aardvark Therapeutics CFO and COO Sun Nelson Disposes of USD 395,790.45 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662082041","title":"Aardvark Therapeutics Lawsuit Alleges Investors Were Misled Before Major AARD Stock Drops","url":"https://stock-news.laohu8.com/highlight/detail?id=2662082041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662082041?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:47","pubTimestamp":1787852846,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics, Inc. (NASDAQ: AARD) is facing a federal securities lawsuit alleging that investors were misled about the safety, tolerabilit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/aardvark-therapeutics-lawsuit-alleges-investors-were-misled-before-major-aard-stock-drops?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/aardvark-therapeutics-lawsuit-alleges-investors-were-misled-before-major-aard-stock-drops?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JEPQ","QDTE","GPIQ","TQQQ","QQQA","QQQM","TQQY","QQQE","AARD","ONEQ","BK4211","TECS","NDX","NQmain","QQQ","MNQmain",".IXIC","IYW","BK4007","QID","QQQY","ISBC","SQQQ","QQQJ","FTEC","QLD","QYLG","NVIW.SI","PSQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661329772","title":"Aardvark Therapeutics Lawsuit Alleges Investors Were Misled Before Sharp AARD Stock Drops","url":"https://stock-news.laohu8.com/highlight/detail?id=2661329772","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661329772?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:18","pubTimestamp":1787257097,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics, Inc. (NASDAQ: AARD) is facing a federal securities lawsuit alleging that investors were misled about the safety profile, reg...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/aardvark-therapeutics-lawsuit-alleges-investors-were-misled-before-sharp-aard-stock-drops?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/aardvark-therapeutics-lawsuit-alleges-investors-were-misled-before-sharp-aard-stock-drops?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","QLD","PSQ","QQQE","QYLG","TQQY","TECS","NVIW.SI","QQQJ",".IXIC","FTEC","AARD","BK4007","SQQQ","QQQ","GPIQ","QQQM","MNQmain","ONEQ","IYW","QID","QQQA","TQQQ","NDX","NQmain","QQQY","BK4211","JEPQ","QDTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660087432","title":"Aardvark Therapeutics Shareholders Approve Governance and Incentives","url":"https://stock-news.laohu8.com/highlight/detail?id=2660087432","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660087432?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:56","pubTimestamp":1787000185,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Aardvark Therapeutics, Inc. ( ($AARD) ). At its August 14, 2026 annual meeting, Aardvark Therapeutics, Inc. rec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aardvark-therapeutics-shareholders-approve-governance-and-incentives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aardvark-therapeutics-shareholders-approve-governance-and-incentives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660434014","title":"Aardvark Therapeutics Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660434014","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660434014?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:11","pubTimestamp":1786997466,"startTime":"0","endTime":"0","summary":"Aardvark Therapeutics held annual shareholder meetingAardvark Therapeutics held its 2026 annual shareholder meeting on Aug. 14, 2026.Shareholders ratified BDO USA as independent auditor for the year e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLPz3gH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659123665","title":"Analysts Offer Insights on NA Companies: Nakamoto Inc (NAKA) and Aardvark Therapeutics, Inc. (AARD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659123665","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659123665?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:40","pubTimestamp":1786725608,"startTime":"0","endTime":"0","summary":"Companies in the NA sector have received a lot of coverage today as analysts weigh in on Nakamoto Inc (NAKA) and Aardvark Therapeutics, Inc. (AARD)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-nakamoto-inc-naka-and-aardvark-therapeutics-inc-aard-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-nakamoto-inc-naka-and-aardvark-therapeutics-inc-aard-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","NAKA","NA","BK4141","BK4007","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659508152","title":"PDS Biotechnology Q2 Net Loss Widens Slightly as Operating Costs Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2659508152","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659508152?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:39","pubTimestamp":1786624789,"startTime":"0","endTime":"0","summary":"PDS Biotechnology Q2 net loss widens slightly as operating costs fallOverviewUS cancer immunotherapy developer's Q2 net loss widened slightly yr/yrOperating expenses fell due to lower clinical trial a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0LJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AARD","IMNM","PDSB","CRDF","BK4007","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659154351","title":"Grace Therapeutics Q1 Net Loss Widens on Impairment Charges","url":"https://stock-news.laohu8.com/highlight/detail?id=2659154351","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659154351?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:08","pubTimestamp":1786622937,"startTime":"0","endTime":"0","summary":"Grace Therapeutics Q1 net loss widens on impairment chargesOverviewUS biopharma firm's Q1 net loss widened on impairment charges tied to deprioritized programsResearch and admin expenses fell as GTx-1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0JR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AARD","GRCE","BK4007","PLRX","ELOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151345","title":"Stifel Nicolaus Keeps Their Hold Rating on Aardvark Therapeutics, Inc. (AARD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151345","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151345?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:35","pubTimestamp":1786620948,"startTime":"0","endTime":"0","summary":"In a report released today, James Condulis from Stifel Nicolaus reiterated a Hold rating on Aardvark Therapeutics, Inc., with a price target of $6....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-hold-rating-on-aardvark-therapeutics-inc-aard-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/stifel-nicolaus-keeps-their-hold-rating-on-aardvark-therapeutics-inc-aard-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AARD","SF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659567411","title":"Indaptus Q2 Net Loss Narrows as Costs Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2659567411","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659567411?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:16","pubTimestamp":1786619798,"startTime":"0","endTime":"0","summary":"Indaptus Q2 net loss narrows as costs fallOverviewU.S. immunotherapy biotech's Q2 net loss narrowed, driven by lower clinical and payroll costsCompany discontinued Decoy20 clinical study and has no ac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TXMD","PLRX","INDP","BK4139","AARD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://aardvarktherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1596},{"period":"1month","weight":-0.3048},{"period":"3month","weight":-0.3849},{"period":"6month","weight":-0.3237},{"period":"1year","weight":-0.708},{"period":"ytd","weight":-0.715}],"compareEarnings":[{"period":"1week","weight":-0.0149},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.0243},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.1537},{"period":"ytd","weight":0.124}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Aardvark Therapeutics","nameEN":"Aardvark Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aardvark Therapeutics(AARD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aardvark Therapeutics(AARD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aardvark Therapeutics,AARD,Aardvark Therapeutics股票,Aardvark Therapeutics股票老虎,Aardvark Therapeutics股票老虎国际,Aardvark Therapeutics行情,Aardvark Therapeutics股票行情,Aardvark Therapeutics股价,Aardvark Therapeutics股市,Aardvark Therapeutics股票价格,Aardvark Therapeutics股票交易,Aardvark Therapeutics股票购买,Aardvark Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aardvark Therapeutics(AARD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aardvark Therapeutics(AARD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}